Harvest Portfolios Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Harvest Portfolios Group's AZN Position: Q2 2026 in Review
Harvest Portfolios Group increased its AstraZeneca (AZN) stake by 0.83% in Q2 2026, buying an estimated $592K and bringing the position to 380,770 shares worth $72.2M. The position accounts for 1.02% of the portfolio, ranked #28.
Harvest Portfolios Group first reported a position in AZN in Q4 2022 and has held it in 15 quarters since. The position peaked at $74.5M in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Harvest Portfolios Group held 380,770 shares of AstraZeneca worth $72.2M as of Q2 2026.
- Harvest Portfolios Group bought 3,150 AstraZeneca shares in Q2 2026, an estimated $592K.
- AstraZeneca made up 1.02% of Harvest Portfolios Group's portfolio in Q2 2026, its #28 holding.
- Harvest Portfolios Group first reported a position in AstraZeneca in Q4 2022 and has held it in 15 quarters since.
- Harvest Portfolios Group's AstraZeneca position peaked at $74.5M in Q1 2026.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.